Beijing Leadman Biochemistry Co Ltd
SZSE:300289
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Beijing Leadman Biochemistry Co Ltd
Long-Term Debt
Beijing Leadman Biochemistry Co Ltd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Beijing Leadman Biochemistry Co Ltd
SZSE:300289
|
Long-Term Debt
¥1.2m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Long-Term Debt
¥7.1B
|
CAGR 3-Years
62%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Long-Term Debt
¥2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Long-Term Debt
¥751.9m
|
CAGR 3-Years
93%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Long-Term Debt
¥4B
|
CAGR 3-Years
41%
|
CAGR 5-Years
85%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Long-Term Debt
¥5.5m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Leadman Biochemistry Co Ltd
Glance View
Beijing Leadman Biochemistry Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. The company is headquartered in Beijing, Beijing and currently employs 522 full-time employees. The company went IPO on 2012-02-16. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The firm also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The firm mainly operates businesses in domestic market.
See Also
What is Beijing Leadman Biochemistry Co Ltd's Long-Term Debt?
Long-Term Debt
1.2m
CNY
Based on the financial report for Dec 31, 2025, Beijing Leadman Biochemistry Co Ltd's Long-Term Debt amounts to 1.2m CNY.
What is Beijing Leadman Biochemistry Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
-48%
Over the last year, the Long-Term Debt growth was 61%. The average annual Long-Term Debt growth rates for Beijing Leadman Biochemistry Co Ltd have been -48% over the past three years .
